Neuroimaging Measures as Endophenotypes in Alzheimer′s Disease
Open accessThe DOI matches its Crossref record; 44 of the 44 references it cites were found in a registry or an index.
Abstract
Late onset Alzheimer′s disease (AD) is moderately to highly heritable. Apolipoprotein E allele ε 4 (APOE4) has been replicated consistently as an AD risk factor over many studies, and recently confirmed variants in other genes such as CLU, CR1, and PICALM each increase the lifetime risk of AD. However, much of the heritability of AD remains unexplained. AD is a complex disease that is diagnosed largely through neuropsychological testing, though neuroimaging measures may be more sensitive for detecting the incipient disease stages. Difficulties in early diagnosis and variable environmental contributions to the disease can obscure genetic relationships in traditional case‐control genetic studies. Neuroimaging measures may be used as endophenotypes for AD, offering a reliable, objective tool to search for possible genetic risk factors. Imaging measures might also clarify the specific mechanisms by which proposed risk factors influence the brain.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Harold, D., Abraham, R., Hollingworth, P., Sims, R., Gerrish, A., Hamshere, M. L., Pahwa, J. S., Moskvina, V., Dowzell, K., Williams, A., et al. (2009) · Nature Genetics · doi:10.1038/ng.440 · Cited by 3,326
Candidate gene for the chromosome 1 familial Alzheimer’s disease locus
Levy-Lahad, E., Wasco, W., Poorkaj, P., Romano, D. M., Oshima, J., Pettingell, W. H., Yu, C.-E., Jondro, P. D., Schmidt, S. D., Wang, K., et al. (1995) · Science · doi:10.1126/science.7638622 · Cited by 2,577 · cited 1×
“Mutations in the amyloid precursor protein (APP) [4], presenilin 1 (PSEN1) [5], and presenilin 2 (PSEN2) [6, 7] genes are known to lead to early onset, familial AD.”
BackgroundGenome-wide association study identifies variants at CLU and CR1 associated with Alzheimer's disease
the European Alzheimer's Disease Initiative Investigators, Lambert, J.-C., Heath, S., Even, G., Campion, D., Sleegers, K., Hiltunen, M., Combarros, O., Zelenika, D., Bullido, M. J., et al. (2009) · Nature Genetics · doi:10.1038/ng.439 · Cited by 2,234
Rogaev, E. I., Sherrington, R., Rogaeva, E. A., Levesque, G., Ikeda, M., Liang, Y., Chi, H., Lin, C., Holman, K., Tsuda, T., et al. (1995) · Nature · doi:10.1038/376775a0 · Cited by 2,052 · cited 1×
“Mutations in the amyloid precursor protein (APP) [4], presenilin 1 (PSEN1) [5], and presenilin 2 (PSEN2) [6, 7] genes are known to lead to early onset, familial AD.”
BackgroundSystematic meta-analyses of Alzheimer disease genetic association studies: the AlzGene database
Bertram, L., McQueen, M. B., Mullin, K., Blacker, D., & Tanzi, R. E. (2007) · Nature Genetics · doi:10.1038/ng1934 · Cited by 1,857 · cited 15×
“All three are listed as top AD risk genes [9] and also affect the cardiovascular system, so it makes sense to examine their additive effects on the brain.”
BackgroundInfluentialRole of Genes and Environments for Explaining Alzheimer Disease
Gatz, M., Reynolds, C. A., Fratiglioni, L., Johansson, B., Mortimer, J. A., Berg, S., Fiske, A., & Pedersen, N. L. (2006) · Archives of General Psychiatry · doi:10.1001/archpsyc.63.2.168 · Cited by 1,798 · cited 3×
“Several initiatives, such as Alzheimer’s Disease Neuroimaging Initiative (ADNI) (www.loni.ucla.edu/ADNI), are now searching for new gene risk variants using neuroimaging traits that are highly heritable, easily measured in a reliable way, and associated with AD [83].”
MethodInfluentialFrequency of Stages of Alzheimer-Related Lesions in Different Age Categories
Braak, H., & Braak, E. (1997) · Neurobiology of Aging · doi:10.1016/s0197-4580(97)00056-0 · Cited by 1,656
Distinct patterns of brain activity in young carriers of the APOE -ε4 allele
Filippini, N., MacIntosh, B. J., Hough, M. G., Goodwin, G. M., Frisoni, G. B., Smith, S. M., Matthews, P. M., Beckmann, C. F., & Mackay, C. E. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0811879106 · Cited by 1,613
Patterns of Brain Activation in People at Risk for Alzheimer's Disease
Bookheimer, S. Y., Strojwas, M. H., Cohen, M. S., Saunders, A. M., Pericak-Vance, M. A., Mazziotta, J. C., & Small, G. W. (2000) · New England Journal of Medicine · doi:10.1056/nejm200008173430701 · Cited by 1,328
Genome-wide Analysis of Genetic Loci Associated With Alzheimer Disease
Seshadri, S. (2010) · JAMA · doi:10.1001/jama.2010.574 · Cited by 1,219
The neuronal sortilin-related receptor SORL1 is genetically associated with Alzheimer disease
Rogaeva, E., Meng, Y., Lee, J. H., Gu, Y., Kawarai, T., Zou, F., Katayama, T., Baldwin, C. T., Cheng, R., Hasegawa, H., et al. (2007) · Nature Genetics · doi:10.1038/ng1943 · Cited by 1,167 · cited 1×
“The gene product is a low-density lipoprotein receptor that may be involved in processing the amyloid precursor protein [56].”
BackgroundDynamics of Gray Matter Loss in Alzheimer's Disease
Thompson, P. M., Hayashi, K. M., de Zubicaray, G., Janke, A. L., Rose, S. E., Semple, J., Herman, D., Hong, M. S., Dittmer, S. S., Doddrell, D. M., et al. (2003) · The Journal of Neuroscience · doi:10.1523/jneurosci.23-03-00994.2003 · Cited by 1,132 · cited 1×
“In the EPHA4 gene, rs10932886 was correlated with gray matter density in the left precuneus and bilateral frontal regions— regions in which atrophy occurs in late AD [105].”
BackgroundSelf-citationMidlife blood pressure and dementia: the Honolulu–Asia aging study☆
Launer, L. J., Ross, G. W., Petrovitch, H., Masaki, K., Foley, D., White, L. R., & Havlik, R. J. (2000) · Neurobiology of Aging · doi:10.1016/s0197-4580(00)00096-8 · Cited by 1,008 · cited 1×
“The candidate gene approach also may be used to evaluate the effects of genes predisposing subjects to characteristics (such as hypertension, obesity, high cholesterol, and diabetes) that increase the risk of AD [73–75] without necessarily being directly involved in the development of classic AD pathology such as amyl…”
BackgroundAmyloid imaging results from the Australian Imaging, Biomarkers and Lifestyle (AIBL) study of aging
Rowe, C. C., Ellis, K. A., Rimajova, M., Bourgeat, P., Pike, K. E., Jones, G., Fripp, J., Tochon-Danguy, H., Morandeau, L., O'Keefe, G., et al. (2010) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2010.04.007 · Cited by 986 · cited 1×
“or cortical thickness (measures of structural gray matter integrity) [27–31], white matter integrity [32–35], cerebral blood flow [36–39], and AD-related pathology such as amyloid and neurofibrillary tangle load [40–44].”
BackgroundAPOE predicts amyloid‐beta but not tau Alzheimer pathology in cognitively normal aging
Morris, J. C., Roe, C. M., Xiong, C., Fagan, A. M., Goate, A. M., Holtzman, D. M., & Mintun, M. A. (2010) · Annals of Neurology · doi:10.1002/ana.21843 · Cited by 830
Cerebral metabolic and cognitive decline in persons at genetic risk for Alzheimer’s disease
Small, G. W., Ercoli, L. M., Silverman, D. H. S., Huang, S.-C., Komo, S., Bookheimer, S. Y., Lavretsky, H., Miller, K., Siddarth, P., Rasgon, N. L., et al. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.090106797 · Cited by 790 · cited 1×
“entorhinal cortex [82], and posterior cingulate cortex [15] may be helpful in further elucidating the links between AD and cardiovascular health.”
BackgroundReiman, E. M., Chen, K., Liu, X., Bandy, D., Yu, M., Lee, W., Ayutyanont, N., Keppler, J., Reeder, S. A., Langbaum, J. B. S., et al. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0900345106 · Cited by 785 · cited 1×
“or cortical thickness (measures of structural gray matter integrity) [27–31], white matter integrity [32–35], cerebral blood flow [36–39], and AD-related pathology such as amyloid and neurofibrillary tangle load [40–44].”
BackgroundMeta-analysis of Alzheimer’s disease risk with obesity, diabetes, and related disorders
Profenno, L. A., Porsteinsson, A. P., & Faraone, S. V. (2010) · Biological Psychiatry · doi:10.1016/j.biopsych.2009.02.013 · Cited by 718
Estimation of significance thresholds for genomewide association scans
Dudbridge, F., & Gusnanto, A. (2008) · Genetic Epidemiology · doi:10.1002/gepi.20297 · Cited by 703 · cited 2×
“2×10−8 [121].”
BackgroundSchuff, N., Woerner, N., Boreta, L., Kornfield, T., Shaw, L. M., Trojanowski, J. Q., Thompson, P. M., Jack, C. R., Weiner, M. W., & Initiative, T. A. D. N. (2008) · Brain · doi:10.1093/brain/awp007 · Cited by 679
Self-citationComparing predictors of conversion and decline in mild cognitive impairment
Landau, S. M., Harvey, D., Madison, C. M., Reiman, E. M., Foster, N. L., Aisen, P. S., Petersen, R. C., Shaw, L. M., Trojanowski, J. Q., Jack, C. R., et al. (2010) · Neurology · doi:10.1212/wnl.0b013e3181e8e8b8 · Cited by 616 · cited 1×
“For instance, glucose metabolism as measured with FDG-PET [100–102], and cerebral perfusion as measured with arterial spin labeling [103] also may predict cognitive decline, but large-scale heritability studies of these measures in healthy older adults are needed to ascertain their potential for identifying genetic in…”
Baseline MRI predictors of conversion from MCI to probable AD in the ADNI cohort
Risacher, S., Saykin, A., Wes, J., Shen, L., Firpi, H., & McDonald, B. (2009) · Current Alzheimer Research · doi:10.2174/156720509788929273 · Cited by 538 · cited 1×
“Both increased ventricular volume [85–88] and decreased volume of medial temporal lobe structures, especially the hippocampus [87–92] predict cognitive decline, are moderately to highly heritable [93–95], and are associated with AD and genetic risk for AD (Table 2).”
BackgroundMorris, J. C., Roe, C. M., Grant, E. A., Head, D., Storandt, M., Goate, A. M., Fagan, A. M., Holtzman, D. M., & Mintun, M. A. (2009) · Archives of Neurology · doi:10.1001/archneurol.2009.269 · Cited by 476
Saykin, A. J., Shen, L., Foroud, T. M., Potkin, S. G., Swaminathan, S., Kim, S., Risacher, S. L., Nho, K., Huentelman, M. J., Craig, D. W., et al. (2010) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2010.03.013 · Cited by 442
Self-citationHeritability for Alzheimer’s disease: the study of dementia in Swedish twins
Gatz, M., Pedersen, N. L., Berg, S., Johansson, B., Johansson, K., Mortimer, J. A., Posner, S. F., Viitanen, M., Winblad, B., & Ahlbom, A. (1997) · The Journals of Gerontology Series A: Biological Sciences and Medical Sciences · doi:10.1093/gerona/52a.2.m117 · Cited by 413
Genetics of brain fiber architecture and intellectual performance
Chiang, M.-C., Barysheva, M., Shattuck, D. W., Lee, A. D., Madsen, S. K., Avedissian, C., Klunder, A. D., Toga, A. W., McMahon, K. L., de Zubicaray, G. I., et al. (2009) · The Journal of Neuroscience · doi:10.1523/jneurosci.4184-08.2009 · Cited by 406 · cited 1×
“Other measures that show promise in predicting cognitive decline are brain amyloid burden as measured using Pittsburgh Compound B [96] and white matter integrity (in general and perhaps more specifically in the parietal lobe) as measured with diffusion tensor imaging [97] both of which are also highly heritable [98, 9…”
MethodSelf-citationPotkin, S. G., Guffanti, G., Lakatos, A., Turner, J. A., Kruggel, F., Fallon, J. H., Saykin, A. J., Orro, A., Lupoli, S., Salvi, E., et al. (2009) · PLoS ONE · doi:10.1371/journal.pone.0006501 · Cited by 376 · cited 7×
“Potkin et al. (2009) used a genomewide search for polymorphisms affecting hippocampal gray matter density, and identified novel AD susceptibility genes in 381 subjects who had AD or were normal controls [108].”
BackgroundMethodInfluentialfMRI evidence of compensatory mechanisms in older adults at genetic risk for Alzheimer disease
Bondi, M. W., Houston, W. S., Eyler, L. T., & Brown, G. G. (2005) · Neurology · doi:10.1212/01.wnl.0000150885.00929.7e · Cited by 372
Butler, M. H., David, C., Ochoa, G.-C., Freyberg, Z., Daniell, L., Grabs, D., Cremona, O., & Camilli, P. D. (1997) · The Journal of Cell Biology · doi:10.1083/jcb.137.6.1355 · Cited by 256 · cited 1×
“Finally, BIN1, which encodes bridging integrator 1—a protein involved in neurite growth [53]— was correlated with temporal pole cortical thickness [47].”
BackgroundEffect of APOE genotype on amyloid plaque load and gray matter volume in Alzheimer disease
Drzezga, A., Grimmer, T., Henriksen, G., Mühlau, M., Perneczky, R., Miederer, I., Praus, C., Sorg, C., Wohlschläger, A., Riemenschneider, M., et al. (2009) · Neurology · doi:10.1212/wnl.0b013e3181a2e8d0 · Cited by 248
Mosconi, L., De Santi, S., Brys, M., Tsui, W. H., Pirraglia, E., Glodzik-Sobanska, L., Rich, K. E., Switalski, R., Mehta, P. D., Pratico, D., et al. (2008) · Biological Psychiatry · doi:10.1016/j.biopsych.2007.05.030 · Cited by 238
Genetic Variation and Neuroimaging Measures in Alzheimer Disease
Biffi, A. (2010) · Archives of Neurology · doi:10.1001/archneurol.2010.108 · Cited by 222 · cited 3×
“Finally, BIN1, which encodes bridging integrator 1—a protein involved in neurite growth [53]— was correlated with temporal pole cortical thickness [47].”
BackgroundBrain imaging evidence of preclinical Alzheimer's disease in normal aging
Jagust, W., Gitcho, A., Sun, F., Kuczynski, B., Mungas, D., & Haan, M. (2006) · Annals of Neurology · doi:10.1002/ana.20799 · Cited by 222 · cited 1×
“For instance, glucose metabolism as measured with FDG-PET [100–102], and cerebral perfusion as measured with arterial spin labeling [103] also may predict cognitive decline, but large-scale heritability studies of these measures in healthy older adults are needed to ascertain their potential for identifying genetic in…”
Boosting power for clinical trials using classifiers based on multiple biomarkers
Kohannim, O., Hua, X., Hibar, D. P., Lee, S., Chou, Y.-Y., Toga, A. W., Jack, C. R., Weiner, M. W., & Thompson, P. M. (2010) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2010.04.022 · Cited by 190 · cited 1×
“In addition, the large number of statistical tests involved in a genome-wide and/or image wide search requires special methods to boost power, including gene-based tests [126], ridge regression models [127], multilocus modeling, and meta-analysis.”
BackgroundSelf-citationSerial MRI and CSF biomarkers in normal aging, MCI, and AD
Vemuri, P., Wiste, H. J., Weigand, S. D., Knopman, D. S., Trojanowski, J. Q., Shaw, L. M., Bernstein, M. A., Aisen, P. S., Weiner, M., Petersen, R. C., et al. (2010) · Neurology · doi:10.1212/wnl.0b013e3181e7ca82 · Cited by 154
Contactins: Emerging key roles in the development and function of the nervous system
Shimoda, Y., & Watanabe, K. (2009) · Cell Adhesion & Migration · doi:10.4161/cam.3.1.7764 · Cited by 149 · cited 1×
“CNTN5, which codes for contactin 5—a protein that may play a role in regional axonal development [50]—is not currently listed as a top AD risk gene [9].”
BackgroundHua, X., Lee, S., Yanovsky, I., Leow, A. D., Chou, Y.-Y., Ho, A. J., Gutman, B., Toga, A. W., Jack, C. R., Bernstein, M. A., et al. (2009) · NeuroImage · doi:10.1016/j.neuroimage.2009.07.011 · Cited by 145 · cited 9×
“Follow-up studies of this polymorphism that evaluate brain atrophy using MRI or amyloid load using PET imaging may be valuable.”
MethodInfluentialSelf-citationStein, J. L., Hua, X., Morra, J. H., Lee, S., Hibar, D. P., Ho, A. J., Leow, A. D., Toga, A. W., Sul, J. H., Kang, H. M., et al. (2010) · NeuroImage · doi:10.1016/j.neuroimage.2010.02.068 · Cited by 145 · cited 5×
“Additionally, at a significance level of P < 5 × 10−7, the authors identified two SNPs that were associated with bilateral temporal lobe volume across diagnoses: rs10845840 in the GRIN2B gene (independent of an APOE4 effect), and rs2456930, located in an intergenic region of chromosome 15 [81].”
BackgroundMethodInfluentialSelf-citationEvidence for CALM in Directing VAMP2 Trafficking
Harel, A., Wu, F., Mattson, M. P., Morris, C. M., & Yao, P. J. (2008) · Traffic · doi:10.1111/j.1600-0854.2007.00694.x · Cited by 144 · cited 1×
“Additionally, a variant in the PICALM gene, which codes for phosphatidylinositol binding clathrin assembly protein—a protein involved in regulating the fusion of synaptic vesicles [52]—was correlated with hippocampal volume.”
BackgroundA diffusion tensor MRI study of patients with MCI and AD with a 2-year clinical follow-up
Scola, E., Bozzali, M., Agosta, F., Magnani, G., Franceschi, M., Sormani, M. P., Cercignani, M., Pagani, E., Falautano, M., Filippi, M., et al. (2010) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.2009.189639 · Cited by 98
APOE related alterations in cerebral activation even at college age
Scarmeas, N. (2005) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.2004.053645 · Cited by 97 · cited 1×
“or cortical thickness (measures of structural gray matter integrity) [27–31], white matter integrity [32–35], cerebral blood flow [36–39], and AD-related pathology such as amyloid and neurofibrillary tangle load [40–44].”
BackgroundCuenco, K. T. (2008) · Archives of Neurology · doi:10.1001/archneur.65.12.1640 · Cited by 61
Heritability of brain ventricle volume: Converging evidence from inconsistent results
Kremen, W. S., Panizzon, M. S., Neale, M. C., Fennema-Notestine, C., Prom-Wormley, E., Eyler, L. T., Stevens, A., Franz, C. E., Lyons, M. J., Grant, M. D., et al. (2012) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2010.02.007 · Cited by 50
Lunetta, K. L., Erlich, P. M., T.Cuenco, K., Adrienne Cupples, L., Green, R. C., Farrer, L. A., & DeCarli, C. (2007) · Alzheimer Disease & Associated Disorders · doi:10.1097/wad.0b013e3180653bf7 · Cited by 34 · cited 1×
“Both increased ventricular volume [85–88] and decreased volume of medial temporal lobe structures, especially the hippocampus [87–92] predict cognitive decline, are moderately to highly heritable [93–95], and are associated with AD and genetic risk for AD (Table 2).”
Background
Cited by
The multiplex model of the genetics of Alzheimer's disease
Sims, R., Hill, M., & Williams, J. (2020) · Nature Neuroscience · doi:10.1038/s41593-020-0599-5 · Cited by 466
Jahanshad, N., Kochunov, P. V., Sprooten, E., Mandl, R. C., Nichols, T. E., Almasy, L., Blangero, J., Brouwer, R. M., Curran, J. E., de Zubicaray, G. I., et al. (2013) · NeuroImage · doi:10.1016/j.neuroimage.2013.04.061 · Cited by 393
“…of common variants in genes associated with neurodegeneration such as APOE (Honea et al., 2009; Jahanshad et al., 2012d; Westlye et al., 2012), CLU (Braskie et al., 2011a), HFE (Jahanshad et al., 2012b), as well as genes associated with psychiatric disorders including BDNF (Chiang et al., 2011a;…”
BackgroundSelf-citationElliott, M. L., Knodt, A. R., Cooke, M., Kim, M. J., Melzer, T. R., Keenan, R., Ireland, D., Ramrakha, S., Poulton, R., Caspi, A., et al. (2019) · NeuroImage · doi:10.1016/j.neuroimage.2019.01.068 · Cited by 304
Kochunov, P., Jahanshad, N., Sprooten, E., Nichols, T. E., Mandl, R. C., Almasy, L., Booth, T., Brouwer, R. M., Curran, J. E., de Zubicaray, G. I., et al. (2014) · NeuroImage · doi:10.1016/j.neuroimage.2014.03.033 · Cited by 133
“…effects of specific genetic variants on the human brain and may also discover genetic variants associated with neurological or psychiatric illnesses (Braskie et al., 2011; Chen et al., 2012; Glahn et al., 2007, 2010; Hasler and Northoff, 2011; Thompson et al., 2001; van den Heuvel et al., 2013).”
BackgroundSelf-citation
Metadata
- Authors
- Braskie, M. N., Ringman, J. M., & Thompson, P. M.
- Venue
- International Journal of Alzheimer’s Disease
- Publisher
- Wiley
- Published
- 2011-01
- Volume
- 2011
- Issue
- 1
- Pages
- 490140-490140
- ISSN
- 2090-0252 (ISSN-L)
- 2090-8024
- OpenAlex
- W2040320905
- Cited by
- 60
- References
- 44
- FWCI
- 5.52
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.